Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
about
Recent advances in the diagnosis and treatment of childhood tuberculosisBeyond empiricism: informing vaccine development through innate immunity researchAntituberculosis therapy for 2012 and beyondImmune vulnerability of infants to tuberculosisMycobacterium tuberculosis: success through dormancyRecent advances towards tuberculosis control: vaccines and biomarkersVaccines against tuberculosis: where are we and where do we need to go?Vaccines for TB: Lessons from the Past Translating into Future PotentialsVaccines for the 21st centuryPrime-boost approaches to tuberculosis vaccine developmentStructural analysis of Mycobacterium tuberculosis ATP-binding cassette transporter subunit UgpB reveals specificity for glycerophosphocholineTuberculosis vaccines: barriers and prospects on the quest for a transformative toolMemory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis AntigensTrypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccineSimultaneous immunization against tuberculosisCD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.The 30-kDa and 38-kDa antigens from Mycobacterium tuberculosis induce partial maturation of human dendritic cells shifting CD4(+) T cell responses towards IL-4 production.Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model.Clonal immune responses of Mycobacterium-specific γδ T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection.National and international policies to mitigate disease threatsMycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosisNew approaches in the diagnosis and treatment of latent tuberculosis infectionThe Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis.Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosisThe tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceA multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.Nanomedicine as an emerging approach against intracellular pathogensRecent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.Mycobacterial shuttle vectors designed for high-level protein expression in infected macrophages.Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.
P2860
Q26797426-B6E4185B-164C-4D24-8F8E-FD576438496DQ26824573-29B96EEE-1AD7-47AE-A4C9-2437755169B4Q26829101-B638A409-18D1-49CB-9429-33892D176DF3Q26829220-C89457E4-EEB6-4EF0-B397-04CE39C87CDCQ26852023-F3B46C1F-01B2-4B88-A2D8-BE1E207CFC97Q26859739-298CBDCA-1BB0-47B4-9A2B-B912DA426CA6Q26992233-6F190D19-39F0-451F-ACAB-F93BC2E86790Q26996673-FA9A0B45-8DA8-42BB-A87E-7712A45EE1D5Q27007529-734BA3E6-25BB-48E1-8F3F-F4BBCC1EC701Q27024526-E734834A-7D51-4F91-88AD-103CC46DFF0EQ27687788-B46C5E0C-03EC-4CF2-9482-8DD4E59121C7Q28390218-0AB77AEC-9F6A-417B-8B59-BBBC3DAE04ACQ28391029-EC241761-0960-491B-8E94-38B1653B4E06Q28483146-6DDFA531-7C62-47B8-8CCD-146172CFD865Q28742666-42A5A4C1-EA1E-4D3D-8D82-0E51AFB30170Q30584398-E11AADA6-1F75-4D4D-AA69-0D60B03C05B8Q31028998-FEBDF365-1CAE-4F43-9CCA-DC889D7F0AF4Q31140592-7552EFA8-5BD4-4B83-98C3-1DB412AE31AAQ33827831-FE94FD48-459F-4399-B408-2DBDCDB69E4EQ33992101-603D89BF-1F63-4F28-A9BB-6C75DAFE23AEQ34097601-00D6BDC2-0776-43E0-A055-002D1A7C1BA1Q34154610-AF83CB26-4703-4B0B-A465-91416E8F3DC6Q34299007-F0143C47-782C-47D9-8D7C-45CED96AF246Q34334767-D4E16FB4-804A-471D-B20D-2A8CAB7B2518Q34419185-7F41F670-57C2-412D-9E3D-A0DF3420016BQ34462437-ED3542B9-EF6C-4DA9-9423-D1E4E5684930Q34531535-815E7A0E-7972-4590-9F36-A6BC7613A815Q35039934-DCCCEC40-414E-4A1B-8362-6DBE64BA1682Q35043659-CA0E9289-790B-4062-B37C-93BFB915B589Q35054007-F3227C0C-F972-4C3A-85A7-657CD5AAB239Q35066463-14C6921B-A378-4956-989A-C2999A1A0FA9Q35135987-5C1B1BB7-F4D5-44C7-9DB2-92B6E2F7BBB4Q35518723-C398F978-351F-4830-AB8B-DA70D831611BQ35656908-D89E3368-3D8C-488F-98D0-9A82AC1611FFQ35715390-FD4124A4-98DD-43FB-AF06-40AB668DDBEBQ35717942-477DF30C-7684-4843-B2EC-6ED9DFDAF591Q35758746-C5AA5F26-1E85-42F5-B2B8-29B72958ED4EQ35766002-FFE57372-B6EF-4A21-8E23-4D657088C606Q36277210-AD582154-22E1-4459-8596-64466B11D407Q36302781-0A1707BF-DED2-41D5-B0F8-573AE143585B
P2860
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@ast
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en-gb
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@nl
type
label
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@ast
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en-gb
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@nl
altLabel
Future vaccination strategies against tuberculosis: thinking outside the box
@en
prefLabel
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@ast
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en-gb
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@nl
P3181
P1433
P1476
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
@en
P304
P3181
P356
10.1016/J.IMMUNI.2010.09.015
P407
P577
2010-10-01T00:00:00Z